Patient and physician preferences for treatment of hepatitis C virus infection in Japan: a discrete choice experiment: plain language summary of publication
Daisuke Nakamoto, Yi Piao, Manami Yoshida, Michael LoPresti, Dilip Makhija, Kyung min Kwon, Jamie Zagorski, Masahisa Jinushi, Yuichiro Eguchi · 2026
Read Patient and physician preferences for treatment of hepatitis C virus infection in Japan: a discrete choice experiment: plain language summary of publication by Daisuke Nakamoto, Yi Piao, Manami Yoshida, Michael LoPresti, Dilip Makhija, Kyung min Kwon, Jamie Zagorski, Masahisa Jinushi, Yuichiro Eguchi (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13272975.txt.
Description
Daisuke Nakamoto leads a 2026 plain language summary of a study on what patients and doctors value when choosing hepatitis C treatment in Japan. Hepatitis C is a liver infection that can be cured, and knowing preferences may help people stay in care. The team used a choice questionnaire with 95 patients and 118 doctors.
Both groups ranked total out-of-pocket cost as most important, with safety next. Patients worried more about cost and less about side-effect risk than doctors did. Patients also cared more about how many tablets to take each day than about how long treatment lasts. The authors suggest better awareness of financial aid and simpler regimens, such as one pill a day.
Catalog record
| CREATOR | Daisuke Nakamoto, Yi Piao, Manami Yoshida, Michael LoPresti, Dilip Makhija, Kyung min Kwon, Jamie Zagorski, Masahisa Jinushi, Yuichiro Eguchi |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 5954 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |